J82 Cells

The J82 cell line is derived from a human bladder transitional cell carcinoma, offering a robust in vitro model for studying urothelial cancer. These cells exhibit epithelial morphology and are adherent in culture, making them suitable for a variety of experimental applications, including cancer biology research, drug screening, and molecular analysis. J82 cells are known to express markers characteristic of bladder carcinoma, including cytokeratins, which are valuable for understanding the molecular pathways involved in bladder cancer progression and for identifying potential therapeutic targets. The J82 cell line is particularly useful for studies focusing on the mechanisms of drug resistance, metastasis, and the role of genetic mutations in bladder cancer. Researchers have utilized this cell line to explore the effects of chemotherapeutic agents and to identify novel compounds that may inhibit cancer cell growth. Additionally, J82 cells are frequently used in gene expression studies to investigate the regulation of oncogenes and tumor suppressor genes within the context of bladder cancer. As with all cancer cell lines, J82 should be handled under strict laboratory conditions, ensuring its use is restricted to research applications and not for any therapeutic or in vivo purposes.